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Dear Editor,
The presence of parasomnias in the pediatric clinical practice is 
quite common and requires attention and knowledge of the general 
pediatrician and the clinical psychiatrist. An important point of the 
treatment is the education and reassurance of the parents, whose 
objective is to explain that such conditions are generally benign, 
with no significant complications and of limited course1.
With regard to the importance of these conditions, we have read 
Guzman and Wang’s2 letter with utmost pleasure, since it was 
published in a psychiatry journal allowing psychiatrists to be more 
alert about sleep disorders.
However, we noted some points that remained unclear and we 
think that it is important to clarify them, to better inform and teach 
clinical psychiatrists who will be faced with these disorders in their 
offices.
First of all, we reinforce that the presence of a psychopathology 
is rare in children with sleep terrors; it is often a benign and time-
limited condition.
Comments on “Sleep terror  
disorder: a case report”
Comentários sobre “Terror noturno: relato 
de caso”
More recent data than that referenced in the letter have clarified 
the question about the real prevalence of sleep terror in children. 
The estimation of the prevalence is difficult, because it may be 
hard for parents to establish a difference between sleep terrors 
and somnambulism in questionnaires, once questions ask about 
retrospective symptoms and refer to both parasomnias in the same 
question. Taking that into account, numbers vary from 1.3% to 
27%3 or even 0 to 40%4.
It is not clear if the statement “As a result, these disorders are 
more common in children who have more delta sleep” means that 
children have more delta sleep, which is true, or if those children 
with more delta sleep would develop more common episodes of 
parasomnia. Indeed, recently published data show that children 
with parasomnia may have low delta power in the first sleep 
cycle and slow decline of delta power in successive sleep cycles, 
suggesting a chronic inability to sustain slow-wave sleep5, but 
no data affirm that the increase of delta sleep per se would be a 
risk factor.
The treatment orientation indeed does not include age as a factor 
when initiating medication; this decision is taken merely based on 
the severity of the disorder. Of note, sometimes it is difficult for 
parents to accept giving their little children controlled medication 
(as benzodiazepines) although they have been prescribed by their 
doctor, however this does not lead to serious consequences1.
In order to prevent psychiatrists from giving selective serotonin 
reuptake inhibitors to their cases of sleep terror, we must 
emphasize that the first choice of pharmacological treatment is a 
benzodiazepine or a tricyclic antidepressant. The time of treatment 
must be at least 3 months and if a good response is achieved, 
treatment should not last for more than 6 months. We have 
had excellent outcomes in our outpatient clinic ambulatory with 
the use of clonazepam, 1 to 5 drops (0.125 mg to 0.625 mg) 
at bedtime.
João Guilherme Fiorani Borgio
Department of Psychiatry, Universidade Federal de São 
Paulo (Unifesp), São Paulo (SP), Brazil
Márcia Pradella-Hallinan
Department of Psychobiology, Universidade Federal de São 
Paulo (Unifesp), São Paulo (SP), Brazil
cyberspace into a new window to the world, offering comfort and 
relief. Those showing distractibility or accelerated thinking, in turn, 
may find encouragement in the Internet that allows them to focus 
their attention more accordingly to the speed of their ideas.1
Several studies indicate an association of IA with other psychiatric 
disorders that, when present as comorbidities, predisposes, 
aggravates, or facilitates excessive Internet use, thereby hampering 
the identification and approach of the problem. The failure in 
recognizing it may negatively affect prognosis.2-4
This patient’s history shows the disorder had been long standing, 
although it was never correctly diagnosed, which led to major social 
impacts for not receiving appropriate treatment. 
Andréas Stravogiannis, Cristiano Nabuco de Abreu
Ambulatório Integrado dos Transtornos do Impulso (AMITI), 
Institute of Psychiatry, School of Medicine, Universidade de São 
Paulo (USP), São Paulo (SP), Brazil
79
Disclosures 
 
Writting group 
member 
Employment Research 
grant
1
 
Other research grant or 
medical continuous 
education
2
 
Speaker’s 
honoraria 
Ownership 
interest 
Consultant/ 
Advisory 
board 
Other
3
 
Tatiana Zambrano 
Filomensky 
USP --- --- --- --- --- --- 
Hermano Tavares USP* 
ANJOTI* 
FAPESP** --- Janssen-Cilag* 
Instituto Américo 
Bairral 
--- --- Lundbeck* 
Servier*  
Roche* 
Apsen* 
Wyeth* 
Sandoz* 
Abbott* 
Cristália 
Editora Artes Médicas 
TAM Linhas Aéreas 
* Modest 
** Significant  
*** Significant. Amounts given to the author's institution or to a colleague for research in which the author has participation, not directly to the author. 
Note: USP = Universidade de São Paulo; FAPESP = Fundação de Amparo a Pesquisa de São Paulo; ANJOTI = Associação Nacional do Jogo Patológico e Outros 
Transtornos do Impulso. 
For more information, see Instructions for authors. 
 
Cartas_MONTADAS_V06.indd   79 09.03.09   11:44:16
Cartas aos Editores
Rev Bras Psiquiatr. 2009;31(1):76-81
Disclosures 
 
Writting group 
member 
Employment Research grant
1
 Other research grant or 
medical continuous 
education
2
 
Speaker’s 
honoraria 
Ownership 
interest 
Consultant/ 
Advisory 
board 
Other
3
 
João Guilherme 
Fiorani Borgio 
UNIFESP --- --- --- --- --- --- 
Márcia Pradella-
Hallinan 
UNIFESP --- --- --- --- --- --- 
* Modest 
** Significant  
*** Significant. Amounts given to the author's institution or to a colleague for research in which the author has participation, not directly to the author. 
Note: UNIFESP = Universidade Federal de São Paulo. 
For more information, see Instructions for authors. 
 
References
1.  Mason TB, 2nd, Pack AI. Sleep terrors in childhood. J Pediatr. 
2005;147(3):388-92.
2.  Guzman CS, Wang YP. Sleep terror disorder: a case report. Rev Bras 
Psiquiatr. 2008;30(2):169.
3. Tomas Vila M, Miralles Torres A, Beseler Soto B, Revert Gomar 
M, Sala Langa MJ, Uribelarrea Sierra AI. Sleep patterns and sleep 
disturbances among schoolchildren in the town of Gandia. An Pediatr 
(Barc). 2008;68(3):250-6.
4.  Petit D, Touchette E, Tremblay RE, Boivin M, Montplaisir J. 
Dyssomnias and parasomnias in early childhood. Pediatrics. 
2007;119(5):e1016-25.
5. Szelenberger W, Niemcewicz S, Dabrowska AJ. Sleepwalking and 
night terrors: psychopathological and psychophysiological correlates. 
Int Rev Psychiatry. 2005;17(4):263-70.
Dear Editor,
Bipolar disorder is a common disorder which affects approximately 1% 
of the population and is associated whith chronicity and severity features 
such as low remission rates, high prevalence of clinical and psychiatric 
comorbidities and a significant functional and cognitive impairment1,2. 
Infection with hepatitis C virus (HCV) is a chronic blood-born disease, 
with an estimated general prevalence of 1-2.4%3. Moreover, this 
infection affects 10% to 15% of bipolar disorder patients4. 
Interferon-alpha treatment is used in combination with ribavirin 
in order to eradicate HCV infection promoting  viral clearance rates 
of 54% to 56%4. Despite these clinical benefit, antiviral treatment of 
chronic hepatitis C with interferon-alpha is associated with several 
neuropsychiatric side-effects such as psychosis, major depression, 
and neuropsychological dysfunction5. In addition, psychiatric co-
morbidity has been used as an exclusion criterion in several large 
HCV clinical trials6,7.
As a consequence, the antiviral treatment of HCV-infected 
mental disorder patients is an understudied field, resulting in a 
major unmet clinical need.
Case report: C is a 44-year-old man, married, with a twenty-
year history of bipolar disorder (BD) and chronic hepatitis C, 
genotype 1, with unknown path of infection. His affective disorder 
Bipolar patients treated for  
hepatitis C with interferon alpha
Pacientes com transtorno afetivo bipolar 
tratados com interferon alfa para hepatite C
is characterized by predominance of manic phases and has 
had a favorable response to lithium carbonate 900 mg/day. He 
reported a total of four manic episodes in his life, including one with 
psychotic features, but  has been euthymic for the last two years. 
The patient and his family decided to treat the chronic hepatitis C 
and accepted the conditions to remain in the psychiatric treatment 
and to attend all medical appointments. He initiated the treatment 
with pegylated interferon-alpha 180 μg/wk plus ribavirin 1.200 mg/
day. During antiviral therapy he only presented fatigue and non-
significant weight loss, being able to complete the treatment with 
no occurrence of psychiatric symptoms.  
Discussion: Clinicians, both psychiatrists and hepatologists, are 
often faced with the dilemma of treating HCV-infected individuals 
with bipolar disorder. Although current or previous bipolar disorder 
is still considered a controversial issue for antiviral treatment with 
interferon-alpha, the ability of these severely mentally ill patients 
to tolerate side-effects and adhere to HCV treatment has been 
shown4. It has been demonstrated that several factors would 
influence patient selection for HCV treatment: the clinical course 
of the bipolar illness, compliance with medications, frequency 
of previous hospitalizations, and the presence of a functional 
emotional and psychosocial support system4. In addition, some 
important topics must be continually reinforced by the psychiatric 
team when treating patients with severe mental illness: 1) the need 
for education about the potential to achieve the cure of hepatitis; 
2) avoidance of liver toxins, including drug abuse; 3) information 
about the potential occurrence of neuropsychiatric side-effects, 
including the fact that these can be treatable and reversible. 
Another important topic is that an informed-consent form should 
be applied. The Brazilian Health Ministry Protocol requires that 
psychiatric patients with chronic hepatitis C should only be treated 
with interferon if they are in a stable condition, having regular 
specialist care, and receiving a psychiatric report allowing the 
treatment8.
We have to emphasize that not all bipolar patients can be treated 
for their chronic hepatitis C; only those who are highly motivated 
and engaged in an intensive psychiatric care program are prepared 
for antiviral therapy3,4.
It cannot be forgotten that further prospective, controlled studies, 
randomized by age, gender, genotype, and psychiatric group are 
needed to better investigate the presented issues.    
Lucas C. Quarantini, Vania B. Powell, Fabiana Nery-Fernandes
Teaching Hospital, Universidade Federal da Bahia (UFBA), 
Salvador (BA), Brazil
Irismar R. de Oliveira, Angela Miranda-Scippa
Neuroscience Department, Universidade Federal da Bahia (UFBA),
Salvador (BA), Brazil
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